These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 78432)

  • 1. [Polysaccharides of microorganisms].
    Zakharov IIa; Zdorovenko GM; Kosenko LV; Vasil'ev VN
    Mikrobiol Zh; 1978; 40(2):186-95. PubMed ID: 78432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Basic structures of various lipopolysaccharides in varous enterobacteriaceae, Genetic and serologic studies on R mutants].
    Schmidt G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):472-6. PubMed ID: 4122877
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigens common to human and bacterial cells. II. E. coli 014, the common Enterobacteriaceae antigen, blood groups A and B, and E. coli 086.
    Drach GW; Reed WP; Williams RC
    J Lab Clin Med; 1972 Jan; 79(1):38-46. PubMed ID: 4550231
    [No Abstract]   [Full Text] [Related]  

  • 4. [The exocellular O-antigen polysaccharide of Alcaligenes faecalis].
    Zdorovenko GM; Skripnik SI
    Mikrobiol Zh (1978); 1985; 47(3):65-71. PubMed ID: 2477670
    [No Abstract]   [Full Text] [Related]  

  • 5. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 6. An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b.
    Schneerson R; Bradshaw M; Whisnant JK; Myerowitz RL; Parke JC; Robbins JB
    J Immunol; 1972 Jun; 108(6):1551-62. PubMed ID: 4624175
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of specific polysaccharides of Alcaligenes faecalis and alkali-forming mutants of enterobacteria].
    Rashba EIa; Laushnik GM
    Mikrobiol Zh; 1970; 32(2):163-75. PubMed ID: 5479151
    [No Abstract]   [Full Text] [Related]  

  • 8. [Enterobacterial R basal types, their reaction and differentiation following concanavalin A].
    Mayer H
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):477-83. PubMed ID: 4122878
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross reactions between human transplantation antigens and bacterial lipopolysaccharides.
    Hirata AA; McIntire FC; Terasaki PI; Mittal KK
    Transplantation; 1973 May; 15(5):441-5. PubMed ID: 4575735
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemical structure and biological activities of lipopolysaccharides (author's transl)].
    Kasai N
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():199-217. PubMed ID: 800274
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of anti-HL-A alloantisera by glycoproteins, polysaccharides, and lipopolysaccharides from diverse sources.
    Mittal KK; Terasaki PI; Springer GF; Desai PR; McIntire FC; Hirata AA
    Transplant Proc; 1973 Mar; 5(1):499-506. PubMed ID: 4572110
    [No Abstract]   [Full Text] [Related]  

  • 12. Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1.
    Jennings HJ; Gamian A; Michon F; Ashton FE
    J Immunol; 1989 May; 142(10):3585-91. PubMed ID: 2469720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Appearance of antibodies to one of the general antigens of microorganisms of the intestinal group after administration to animals of carcinogenic substances and in anacid gastritis in man].
    Montsevichiute-Eringene EV
    Patol Fiziol Eksp Ter; 1974; (5):38-44. PubMed ID: 4216001
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent findings on the chemical structure and biological activity of bacterial lipopolysaccharides.
    Lüderitz O; Galanos C; Lehmann V; Rietschel ET
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(4):381-90. PubMed ID: 4141712
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of specific polysaccharides of alkali-forming enterobacteria. I. Selection of hydrolysis conditions for polysaccharides from Bacterium faecalis alcaligenes, strain 6].
    Laushnik GM; Skripnik SI
    Mikrobiol Zh; 1975; 37(5):594-6. PubMed ID: 1219323
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenic epitope in Pseudomonas aeruginosa lipopolysaccharide immunologically cross-reactive with Escherichia coli O26 lipopolysaccharide.
    Yokota S; Kaya S; Noguchi H
    FEMS Microbiol Lett; 1990 Mar; 56(3):245-8. PubMed ID: 1692796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-agglutinin antibodies against Alcaligenes faecalis and Escherichia coli in hepatitis cases and normal subjects--a preliminary communication.
    Pal SR; Ayyagari A; Ramanna BC
    Indian J Med Res; 1978 Feb; 67():207-11. PubMed ID: 355133
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of gram-negative bacterial polysaccharides on various immunity reactions and experimental tumors].
    Slabospyts'ka AT; Zatula DH; Zakharova IIa; Reznyk SR
    Mikrobiol Zh; 1976; 38(6):750-5. PubMed ID: 794646
    [No Abstract]   [Full Text] [Related]  

  • 19. Cross-reactivity with Escherichia coli K100 in the human serum anticapsular antibody response to Haemophilus influenzae type B.
    Insel RA; Anderson PW
    J Immunol; 1982 Mar; 128(3):1267-70. PubMed ID: 7035561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.
    McCabe WR
    J Immunol; 1972 Mar; 108(3):601-10. PubMed ID: 4622185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.